InvestorsHub Logo
Followers 1
Posts 108
Boards Moderated 0
Alias Born 10/08/2013

Re: None

Saturday, 10/25/2014 1:15:13 PM

Saturday, October 25, 2014 1:15:13 PM

Post# of 9932
Yet another potential advantage of PV-10 in avoiding "Dermatologic Adverse Events Associated With Systemic Anticancer Agents" - See more at: http://www.cancernetwork.com/cancer-management/dermatologic-adverse-events-associated-systemic-anticancer-agents?GUID=C04F16C2-DFA0-42B8-80E4-4C643CC67546&XGUID=&rememberme=1&ts=25102014#sthash.1vMlCi1y.dpuf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PVCT News